Intrinsic Value of S&P & Nasdaq Contact Us

Insmed Incorporated INSM NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
52/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$216.39
+41.1%

Stock Statistics — INSM

Insmed Incorporated (INSM) has a market capitalization of $33.07B and trades at $153.40. The 52-week range is 60.4-212.75.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -23.9, Earnings Per Share (EPS) of $-6.41, annual revenue of $606.42M.

The stock has a beta of 1.10, operates in the Healthcare sector.

Trading Data
Current Price$153.40
52-Week Range60.4-212.75
Volume1.27M
Avg Volume (30D)2.53M
Market Cap$33.07B
Beta (1Y)1.10
Company
IPO Date2000-06-01
Employees1,271
CEOWilliam H. Lewis
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS4576693075
CUSIP457669307
Income (Latest Year)
Revenue$606.42M
Gross Profit$481.55M
EBITDA$-1.17B
Operating Income$-1.18B
Net Income$-1.28B
EPS$-6.41
EPS Diluted$-6.41
Shares Outstanding$213.64M
Balance Sheet (Latest Year)
Total Assets$2.26B
Current Assets$1.79B
Cash & ST Investments$1.43B
Total Liabilities$1.53B
Total Debt$768.16M
Net Debt$257.71M
Total Equity$738.98M
Debt / Equity1.04
Valuation Ratios
P/E Ratio-23.9
P/S Ratio54.53
P/B Ratio44.75
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message